Newsroom

SUNNYVALE, Calif.--(BUSINESS WIRE)--Avicena, the pioneer in microLED-based optical interconnects, today announced the LightBundle™ eKit, the industry’s first evaluation platform for microLED optical connectivity using ASIC-based transceivers with integrated LED, photodetector (PD) and micro-lens arrays connected via a multi-core fiber bundle. The kit enables hyperscaler, AI accelerator, high-bandwidth memory (HBM), networking, and AI infrastructure architects to evaluate next-generation optical...

瑞士楚格--(BUSINESS WIRE)--(美國商業資訊)-- 端對端資料管理解決方案專業服務商、Astorg旗下投資組合公司Redslim今日宣布進軍亞太地區，並任命Kyriakos Zannikos為亞太區總監。此舉代表Redslim全球成長策略的重要里程碑，讓公司能夠更貼近身處全球成長速度和資料驅動程度首屈一指的消費市場的客戶。 隨著全球消費品牌加快數位化轉型和AI應用，許多企業仍面臨資料生態系統割裂的問題，相關資料分散在多家代理機構、多個市場和不同資料集中。這些挑戰在亞太地區尤為突顯，多元的市場結構和高速發展造就了複雜的資料環境。 Redslim協助企業將碎片化的市場訊息轉化為有價值的資料資產，協助客戶做出自信決策，釋放資料的全部價值。透過建置穩固的資料基礎，Redslim支援客戶實現資料基礎架構現代化，並為下一代分析和AI驅動能力做好準備。 進軍亞太市場強化了Redslim為在該地區經營業務的全球客戶提供支援的能力，尤其是在快速消費品(FMCG)、消費者保健(CHC)、美妝和精品領域。設立專屬區域機構將使Redslim能夠與本地團隊及合作夥伴密切合作，同時維持支撐其服務的...

瑞士楚格--(BUSINESS WIRE)--(美国商业资讯)-- 端到端数据管理解决方案专业服务商、Astorg旗下投资组合公司Redslim今日宣布进军亚太地区，并任命Kyriakos Zannikos为亚太区总监。此举标志着Redslim全球增长战略的重要里程碑，让公司能够更贴近身处全球增长速度和数据驱动程度首屈一指的消费市场的客户。 随着全球消费品牌加速数字化转型和AI应用，许多企业仍面临数据生态系统割裂的问题，相关数据分散在多家代理机构、多个市场和不同数据集中。这些挑战在亚太地区尤为突出，多元的市场结构和高速发展造就了复杂的数据环境。 Redslim帮助企业将碎片化的市场信息转化为有价值的数据资产，助力客户做出自信决策，释放数据的全部价值。通过搭建稳固的数据基础，Redslim支持客户实现数据基础设施现代化，并为下一代分析和AI驱动能力做好准备。 进军亚太市场强化了Redslim为在该地区运营的全球客户提供支持的能力，尤其是在快速消费品(“FMCG”)、消费者保健(“CHC”)、美妆和奢侈品领域。设立专属区域机构将使Redslim能够与本地团队及合作伙伴紧密协作，同时维持支撑...

TOKIO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (hoofdzetel: Chuo-ku, Tokio, Japan; voorzitter en vertegenwoordigend directeur: Toshiaki Nagasato) maakte vandaag bekend dat het bedrijf een klinische studie van Fase I van ME3241 (ontwikkelingscode) is gestart, een anti-PD-1-agonist monoklonaal antilichaam ontdekt via onderzoek in samenwerking met de FBRI (Foundation for Biomedical Research & Innovation) in Kobe (hoofdzetel: Kobe, Japan; voorzitter: Shuh Narumiya; hierna aangeduid als “F...

TOKYO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (sede centrale: Chuo-ku, Tokyo, Giappone; Presidente e direttore rappresentante delegato: Toshiaki Nagasato) ha annunciato oggi di aver avviato lo studio clinico di Fase I di ME3241 (codice di sviluppo), un anticorpo monoclonale agonista anti-PD-1 scoperto grazie alla ricerca collaborativa condotta con la Foundation for Biomedical Research and Innovation di Kobe (sede centrale: Kobe, Giappone; Presidente: Shuh Narumiya; di seguito "FBRI"). Lo...

TOKIO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (sede central: Chuo-ku, Tokio, Japón; presidente y director representante: Toshiaki Nagasato) acaba de anunciar el inicio de un ensayo clínico de fase I con ME3241 (código de desarrollo), anticuerpo monoclonal agonista anti-PD-1 descubierto gracias a la investigación llevada a cabo junto con la Foundation for Biomedical Research and Innovation at Kobe (sede central: Kobe, Japón; presidente: Shuh Narumiya; en adelante, «FBRI»). Este ensayo clí...

TOKYO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (siège : Chuo-ku, Tokyo, Japon ; Président-directeur général : Toshiaki Nagasato) a annoncé aujourd’hui avoir lancé un essai clinique de phase I sur le ME3241 (code de développement), un anticorps monoclonal agoniste anti-PD-1 découvert dans le cadre d’une recherche collaborative avec la Fondation pour la recherche biomédicale et l’innovation à Kobe (siège social : Kobe, Japon ; président : Shuh Narumiya ; ci-après « FBRI »). L’essai clinique...

TOKIO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (Hauptsitz: Chuo-ku, Tokio, Japan; President und Representative Director: Toshiaki Nagasato) gab heute den Start einer klinischen Phase-I-Studie mit ME3241 (Entwicklungscode) bekannt. Bei diesem Wirkstoff handelt es sich um einen monoklonalen Anti-PD-1-Agonisten-Antikörper, der im Rahmen einer Forschungszusammenarbeit mit der Foundation for Biomedical Research and Innovation at Kobe (Hauptsitz: Kobe, Japan; President: Shuh Narumiya; nachstehe...

GREENWICH, Conn.--(BUSINESS WIRE)--Eagle Point Credit Management LLC (“Eagle Point”), an innovative private credit investment manager, today announced it has provided the second in a series of two senior secured credit financings to Nexus Apex Holdings, LLC, owned by Nexus Data Centers, a data center developer backed by Transition Equity Partners. Nexus Data Centers is developing a ~2,900-acre campus designed to support behind-the-meter power generation, NeoCloud, and high-density hyperscale in...

DOWNERS GROVE, Ill.--(BUSINESS WIRE)--Maker’s Pride announced yesterday it will begin winding down operations at its manufacturing facilities in Salt Lake City, Utah and Shakopee, Minnesota. The closures are expected to be completed in the third quarter of 2026. This decision follows a comprehensive review of the company’s manufacturing network and long-term growth strategy. As Maker’s Pride accelerates investment in strategic growth categories and modernizes its operations with advanced automa...